Scholarlink

<p>Glioblastoma multiforme (GBM) is the most common primary malignancy of the central nervous system, with a poor prognosis despite multimodal treatment approaches. With the development and integration of Magnetic Resonance-guided Linear Accelerator (MR-Linac) technology into the treatment paradigm for high-grade gliomas, there is promising potential for improved treatment precision and reduced side effects for patients diagnosed with this aggressive cancer. The MR-Linac combines high-resolution, real-time magnetic resonance imaging with precise linear accelerator-based treatment delivery, enabling adaptive radiotherapy that adjusts to anatomical changes during the treatment course. This technology offers the potential to refine target delineation, optimize treatment volumes, and reduce radiation exposure to healthy tissue. The editorial discusses the transformative potential of the MR-Linac in improving treatment personalization and outcomes for patients with high-grade gliomas, positioning it as a significant advancement in radiation oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advancements in adaptive MR-guided radiotherapy for high-grade gliomas

  • 期刊论文

  • 发表日期：

    2025年4月24日

查看全文
  • Alexander S. Marwaha,
  • Matthew J. Shepard,
  • Stephen M. Karlovits,
  • John Herbst,
  • Rodney E. Wegner

摘要

Glioblastoma multiforme (GBM) is the most common primary malignancy of the central nervous system, with a poor prognosis despite multimodal treatment approaches. With the development and integration of Magnetic Resonance-guided Linear Accelerator (MR-Linac) technology into the treatment paradigm for high-grade gliomas, there is promising potential for improved treatment precision and reduced side effects for patients diagnosed with this aggressive cancer. The MR-Linac combines high-resolution, real-time magnetic resonance imaging with precise linear accelerator-based treatment delivery, enabling adaptive radiotherapy that adjusts to anatomical changes during the treatment course. This technology offers the potential to refine target delineation, optimize treatment volumes, and reduce radiation exposure to healthy tissue. The editorial discusses the transformative potential of the MR-Linac in improving treatment personalization and outcomes for patients with high-grade gliomas, positioning it as a significant advancement in radiation oncology.